Literature DB >> 9815226

Amphotericin B activation of human genes encoding for cytokines.

P D Rogers1, J K Jenkins, S W Chapman, K Ndebele, B A Chapman, J D Cleary.   

Abstract

Amphotericin B has been shown to cause release of cytokines, including interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha), from monocytes and macrophages. Human and murine monocytic cell lines were used to evaluate the effects of amphotericin B on the transcription of IL-1alpha, IL-1beta, and TNF-alpha and the transcription and production of soluble IL-1 receptor antagonist (sIL-1Ra). The effects of inhibitors of transcription and translation on amphotericin B-induced IL-1beta expression in a human monocytic cell line were also evaluated. Amphotericin B markedly increased IL-1beta and TNF-alpha mRNA levels, with peak levels occurring by 4 h. Amphotericin B induced production of sIL-1Ra in a dose-dependent fashion and induced sIL-1Ra mRNA, with peak levels at 24 h. Cycloheximide and actinomycin D resulted in a dose-dependent decrease in amphotericin B-induced IL-1beta expression at 2 h. Thus, amphotericin B induces gene expression for IL-1beta, TNF-alpha, and IL-1Ra in human and murine monocytic cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9815226     DOI: 10.1086/314495

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Effects of MS-8209, an amphotericin B derivative, on tumor necrosis factor alpha synthesis and human immunodeficiency virus replication in macrophages.

Authors:  P Clayette; M Martin; V Beringue; N Dereuddre-Bosquet; K T Adjou; M Seman; D Dormont
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

Review 2.  Treatment principles for the management of mold infections.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

3.  Reduction of no synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers.

Authors:  M Larabi; P Legrand; M Appel; S Gil; M Lepoivre; J Devissaguet; F Puisieux; G Barratt
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

4.  Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial.

Authors:  U Eriksson; B Seifert; A Schaffner
Journal:  BMJ       Date:  2001-03-10

5.  Dramatic remission of nephrotic syndrome after unusual complication of mucormycosis in idiopathic membranous nephropathy.

Authors:  Wenling Ye; Yingyi Wang; Yubing Wen; Hang Li; Xuemei Li
Journal:  Int Urol Nephrol       Date:  2014-01-11       Impact factor: 2.370

6.  Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2.

Authors:  Raymund R Razonable; Martin Henault; Linda N Lee; Carmen Laethem; Paul A Johnston; Harold L Watson; Carlos V Paya
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

7.  Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin B.

Authors:  M Simitsopoulou; E Roilides; J Dotis; M Dalakiouridou; F Dudkova; E Andreadou; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

8.  Macrophage reporter cell assay for screening immunopharmacological activity of cell wall-active antifungals.

Authors:  Russell E Lewis; Guangling Liao; Katherine Young; Cameron Douglas; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

9.  Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis.

Authors:  Henry W Murray; Elaine B Brooks; Jennifer L DeVecchio; Frederick P Heinzel
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

Review 10.  In search of the holy grail of antifungal therapy.

Authors:  Stanley W Chapman; Donna C Sullivan; John D Cleary
Journal:  Trans Am Clin Climatol Assoc       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.